PHC Signs Exclusive Deal to Distribute MaxCyte Cell Engineering Platform in Japan
Tokyo: The Biomedical Division of PHC Corporation (PHCbi), a subsidiary of PHC Holdings Corporation (PHCHD), has signed an exclusive distribution agreement with the United States-based MaxCyte Inc to bring the company’s advanced ExPERT cell engineering platform to the Japanese market.